Both in Pharmaceuticals
Keros Therapeutics vs Evommune
Over the past year KROS returned −28.2% and EVMN returned −68.8%; their daily moves had a correlation of 0.19.
KROS −28.2% EVMN −68.8%Growth of $1, one year, split-adjusted
| Metric | KROS | EVMN |
|---|---|---|
| Price | $11.61 | $6.36 |
| Market cap | $230.2M | $230.8M |
| Today | +1.62% | +23.25% |
| 1 month | +3.8% | −23.8% |
| 6 months | +4.6% | −73.3% |
| Year to date | −43.0% | −62.9% |
| 1 year | −22.8% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 15.3× | — |
| Net cash | $257.6M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 46.2% | 85.0% |
| Short % of float | 6.2% | 16.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).